Immunocytochemical mapping of the phosphatase and tensin homolog (PTEN/MMAC1) tumor suppressor protein in human gliomas

Neuro-Oncology

Volumn 2, Issue 2, 2000, Pages 71-79

  Fults, Dan ^a   Pedone, Carolyn ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; DNA; FETOPROTEIN; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; NERVE PROTEIN; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOTOPROTEIN; PTEN PROTEIN, HUMAN; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ADOLESCENT; ADULT; AGED; ALLELE; ANIMAL; ARTICLE; ASTROCYTOMA; BRAIN; BRAIN LEVEL; BRAIN TUMOR; CELL STRAIN COS1; CERCOPITHECUS; CHEMISTRY; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSFECTION; GENETICS; GENOTYPE; GESTATIONAL AGE; GLIOBLASTOMA; GLIOMA; HETEROZYGOSITY LOSS; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIOMA; PHYSIOLOGY; PRENATAL DEVELOPMENT; RABBIT; REPORTER GENE; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; ANIMALS; ASTROCYTOMA; BRAIN; BRAIN CHEMISTRY; BRAIN NEOPLASMS; CERCOPITHECUS AETHIOPS; COS CELLS; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; FETAL PROTEINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, REPORTER; GENES, TUMOR SUPPRESSOR; GENOTYPE; GESTATIONAL AGE; GLIOBLASTOMA; GLIOMA; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNE SERA; IMMUNOENZYME TECHNIQUES; LOSS OF HETEROZYGOSITY; LUMINESCENT PROTEINS; MALE; MIDDLE AGED; MUTATION, MISSENSE; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; OLIGODENDROGLIOMA; PHOSPHORIC MONOESTER HYDROLASES; PTEN PHOSPHOHYDROLASE; RABBITS; RECOMBINANT FUSION PROTEINS; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 0034172921     PISSN: 15228517     EISSN: None     Source Type: Journal    
DOI: 10.1093/neuonc/2.2.71     Document Type: Article

References (24)

1. Cook, D.L., Gerber, A.N., and Tapscott, S.J. (1998) Modeling stochastic gene expression: Implications for haploinsufficiency. Proc. Natl. Acad. Sci. U.S.A. 95, 15641-15646.
2. Fults, D., and Pedone, C. (1993) Deletion mapping of the long arm of chromosome 10 in glioblastoma multiforme. Genes Chromosomes Cancer 7, 173-177.
3. Fults, D., Pedone, C.A., Thompson, G.E., Uchiyama, C.M., Gumpper, K.L., Iliev, D., Vinson, V.L., Tavtigian, S.V., and Perry, W.L. (1998) Microsatellite deletion mapping on chromosome 10q and mutation analysis of MMAC1, FAS, and MXI1 in human glioblastoma multiforme. Int. J. Oncol. 12, 905-910.
4. Furnari, F.B., Huang, H.S., and Cavenee, W.K. (1998) The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells. Cancer Res. 58, 5002-5008.
5. Haas-Kogan, D., Shalev, N., Wong, M., Mills, G., Yount, G., and Stokoe, D. (1998) Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC. Curr. Biol. 21, 1195-1198.
6. Hsu, S.M., Raine, L., and Fanger, H. (1981) Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unrelated antibody (PAP) procedures. J. Histochem. Cytochem. 29, 577-580.
7. Kleihues, P., Burger, P.C., and Scheithauer, B.W. (1993) Histological Typing of Tumours of the Central Nervous System. Berlin: Springer-Verlag.
8. Kleihues, P., and Cavenee, W.K. (Eds.) (1997) Pathology and Genetics of Tumours of the Nervous System. Lyon, France: International Agency for Research on Cancer.
9. Li, D.M., and Sun, H. (1997) TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor β. Cancer Res. 57, 2124-2129.
10. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S.I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., Bigner, S.H., Giovanella, B.C., Ittmann, M., Tycko, B., Hibshoosh, H., Wigler, M.H., and Parsons, R. (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943-1947.
11. Liaw, D., Marsh, D.J., Li, J., Dahia, P.L.M., Wang, S.I., Zheng, Z., Bose, S., Call, K.M., Tsou, H.C., Peacocke, M., Eng, C., and Parsons, R. (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet. 16, 64-67.
12. Liu, W., James, C.D., Frederick, L., Aldrete, B.E., and Jenkins, R.B. (1997) PTEN/MMAC1 mutations and EGFR amplification in glioblastomas. Cancer Res. 57, 5254-5257.
13. Maehama, T., and Dixon, J.I. (1998) The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273, 13375-13378.
14. Mrzijak, L., Uylings, H.B.M., Kostovic, I., and Van Eden, C.G. (1988) Prenatal development of neurons in the human prefrontal cortex: A qualitative Golgi study. J. Comp. Neurol. 271, 355-386.
15. Myers, M.P., Stolarov, J.P., Eng, C., Li, J., Wang, S.I., Wigler, M.H., Parsons, R., and Tonks, N.K. (1997) P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc. Natl. Acad. Sci. U.S.A. 94, 9052-9057.
16. Noble, M. (1996) Steps toward a cellular biological analysis of human gliomas. In: Raffel, C., and Harsh, G.R. (Eds.), The Molecular Basis of Neurosurgical Disease. Baltimore: Williams and Wilkins. Vol. 8, pp. 87-97.
17. Ohlsson, R., Tycko, B., and Sapienza, C. (1998) Monoalletic expression: "There can only be one." Trends Genet. 14, 435-438.
18. Rasheed, B.K.A., Stenzel, T.T., McLendon, R.E., Parsons, R., Friedman, A.H., Friedman, H.S., Bigner, D.D., and Bigner, S.H. (1997) PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res. 57, 4187-4190.
19. Sano, T., Lin, H., Chen, X., Langford, L.A., Koul, D., Bondy, M.L., Hess, K.R., Myers, J.N., Hong, Y.K., Yung, W.K.A., and Steck, P.A. (1999) Differential expression of MMAC/PTEN in glioblastoma multiforme: Relationship to localization and prognosis. Cancer Res. 59, 1820-1824.
20. Steck, P.A., Pershouse, M.A., Jasser, S.A., Yung, W.K.A., Lin, H., Ligon, A.H., Langford, L.A., Baumgard, M.L., Hattier, T., Davis, T., Frye, C., Hu, R., Swedlund, B., Teng, D.H.F., and Tavtigian, S.V. (1997) Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet. 15, 356-362.
21. Suzuki, A., de la Pompa, J.L., Stambolic, V., Elia, A.J., Sasaki, T., Barrantes, I.B., Ho, A., Wakeham, A., Itie, A., Khoo, W., Fukumoto, M., and Mak, T.W. (1998) High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr. Biol. 21, 1169-1178.
22. Tamura, M., Gu, J., Matsumoto, K., Aota, S., Parsons, R., and Yamada, K.M. (1998) Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280, 1614-1617.
23. Wang, S.I., Puc, J., Li, J., Bruce, J.N., Cairns, P., Sidransky, D., and Parsons, R. (1997) Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res. 57, 4183-4186.
24. Whang, Y.E., Wu, X., Suzuki, H., Reiter, R.E., Tran, C., Vessella, R.L., Said, J.W., Isaacs, W.B., and Sawyers, C.L. (1998) Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. Proc. Natl. Acad. Sci. U.S.A. 95, 5246-5250.